Don’t miss out on the next big thing in the life sciences.
Big4Bio delivers curated news, insights, events, career opportunities, and updates from the industry's top regions to keep professionals informed and connected. Sign up now to stay in the know!

30K+ Subscribers
8 Key Regions
4 Focus Areas
Jason Cole, CEO and Board Member, Zag Bio, Inc.
In this week’s Big4Bio CEO Q&A, Cole, who lives with type 1 diabetes himself, discusses the scientific breakthrough behind Zag’s thymus-targeted platform, what differentiates the company’s approach from other immune-tolerance strategies in development, the milestones ahead as Zag’s lead program moves toward the clinic, and his outlook for turning immune tolerance from a long-standing scientific aspiration into real therapies for patients.
Browse Our Regional Company Directories
Whether you're seeking potential partners, competitors, or new opportunities, these regional directories serve as a valuable resource for navigating the life sciences landscape.




